logo
Twitter
Discord
Email
logo
FitLife Brands, Inc.

FitLife Brands, Inc.

NASDAQ•FTLF
CEO: Mr. Dayton Robert Judd CPA
Sector: Consumer Defensive
Industry: Packaged Foods
Listing Date: 2007-11-02
FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.
Contact Information
5214 South 136th Street, Omaha, NE, 68137, United States
402-991-5618
www.fitlifebrands.com
Market Cap
$148.66M
P/E (TTM)
22.0
10.8
Dividend Yield
--
52W High
$20.98
52W Low
$9.83
52W Range
54%
Rank33Top 25.7%
4.8
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 4.8 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025

Financial Dashboard

Q3 2025 Data

Revenue

$23.49M+46.99%
4-Quarter Trend

EPS

$0.10-56.52%
4-Quarter Trend

FCF

$3.66M+78.99%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Revenue Jumps Post-Acquisition Quarterly revenue reached $23,485K, surging 47% compared to prior period. Nine month revenue $55,548K, up 12%.
Gross Profit Rises 25% Q3 Gross Profit totaled $8,736K, a 25% increase driven by Irwin acquisition volume and higher MusclePharm sales.
Total Assets Nearly Double Total Assets grew to $109,984K by September 30, 2025, significantly higher than $58,531K reported December 31, 2024.
Net Income Falls Sharply Q3 Net Income $921K decreased 57% versus prior year, impacted by $820K merger expense and lower gross margin.

Risk Factors

Gross Margin Pressure Continues Q3 Gross Margin dropped 6.6 points to 37.2% due to lower margin Irwin sales and $392K inventory step-up amortization.
High Acquisition Expenses Nine month Merger and Acquisition expense reached $1,848K, primarily transaction costs related to the recent Irwin acquisition.
Increased Debt Load Total Liabilities rose to $68,092K, supported by $40,625K outstanding Irwin Term Loan debt following August acquisition funding.
Goodwill Impairment Potential Stock price volatility impacts goodwill valuation; management notes potential impairment if fair value falls below carrying amount.

Outlook

Liquidity Sufficient Twelve Months Cash from operations and reserves expected to provide sufficient liquidity for the next twelve months, despite higher debt.
Finalizing Irwin Asset Valuation Company actively reviewing models for provisional goodwill and intangible assets from the August 8, 2025 Irwin acquisition.
Interest Rate Swap Executed Entered $20,000K interest rate swap to fix approximately 50% of variable rate term loan exposure until August 2030.
Rationalizing Advertising Spend Ongoing efforts focus on rationalizing advertising spend on less effective campaigns while increasing spend on core brands.

Peer Comparison

Revenue (TTM)

The Hain Celestial Group, Inc.HAIN
$1.53B
-10.1%
Nature's Sunshine Products, Inc.NATR
$474.54M
+6.6%
BRC Inc.BRCC
$391.40M
-3.4%

Gross Margin (Latest Quarter)

LifeVantage CorporationLFVN
81.0%
+1.1pp
Nature's Sunshine Products, Inc.NATR
73.3%
+1.9pp
The Beauty Health CompanySKIN
64.6%
+13.0pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
NATR$421.12M28.19.5%5.4%
BRCC$305.58M-6.9-54.3%28.3%
EWCZ$224.44M15.615.5%53.0%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
16.1%
Strong Growth
4Q Net Income CAGR
-23.7%
Declining Profitability
Cash Flow Stability
100%
Strong Cash Flow

Research & Insights

Next earnings:Mar 26, 2026
|
EPS:$0.25
|
Revenue:-
Reports
All Years

  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Nov 13, 2025|
    Revenue: $23.49M+47.0%
    |
    EPS: $0.10-56.5%
    Miss

  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Aug 14, 2025|
    Revenue: $16.13M-4.7%
    |
    EPS: $0.19-33.5%
    Beat

  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 15, 2025|
    Revenue: $15.94M-3.7%
    |
    EPS: $0.22-6.3%
    Miss

  • Form 10-K/A - FY 2024

    Period End: Dec 31, 2024|Filed: Apr 29, 2025|
    Revenue: $64.47M+22.3%
    |
    EPS: $0.98+65.6%
    Beat

  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Mar 27, 2025|Refer to amended data

  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 14, 2024|
    Revenue: $15.98M+14.9%
    |
    EPS: $0.23+20.6%
    Miss

  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 14, 2024|
    Revenue: $16.93M+14.7%
    |
    EPS: $0.29+29.4%
    Miss

  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 14, 2024|
    Revenue: $16.55M+54.1%
    |
    EPS: $0.23+1250.0%
    N/A